Portolan Capital Management, LLC Natera, Inc. Transaction History
Portolan Capital Management, LLC
- $1.29 Billion
- Q1 2024
A detailed history of Portolan Capital Management, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Portolan Capital Management, LLC holds 201,218 shares of NTRA stock, worth $21.4 Million. This represents 1.43% of its overall portfolio holdings.
Number of Shares
201,218
Previous 92,426
117.71%
Holding current value
$21.4 Million
Previous $5.79 Million
217.9%
% of portfolio
1.43%
Previous 0.52%
Shares
4 transactions
Others Institutions Holding NTRA
# of Institutions
439Shares Held
117MCall Options Held
254KPut Options Held
263K-
Vanguard Group Inc Valley Forge, PA11MShares$1.18 Billion0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY7.36MShares$784 Million0.06% of portfolio
-
Fred Alger Management, LLC New York, NY6.55MShares$697 Million3.03% of portfolio
-
Black Rock Inc. New York, NY6.49MShares$691 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.93MShares$418 Million1.68% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $10.3B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...